The expression of claudin 1 correlates with β-catenin and is a prognostic factor of poor outcome in gastric cancer.
暂无分享,去创建一个
Y. Qu | Zhenggang Zhu | Xue-hua Chen | Jian-fang Li | Jie Huang | Li Zhang | Jia-nian Zhang | Bing-ya Liu
[1] A. Bhat,et al. Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. , 2013, Carcinogenesis.
[2] Takuya Suzuki,et al. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells. , 2013, Molecular nutrition & food research.
[3] G. Giamas,et al. Claudin-1 as a promoter of EMT in hepatocellular carcinoma , 2013, Oncogene.
[4] G. Yoon,et al. Claudin-1 induces epithelial–mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells , 2013, Oncogene.
[5] A. Hokama,et al. Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1. , 2013, World journal of gastroenterology.
[6] Wei Wang,et al. Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer , 2013, PloS one.
[7] M. Washington,et al. Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling , 2013, Gut.
[8] L. Murphy,et al. Claudin 1 expression in basal-like breast cancer is related to patient age , 2013, BMC Cancer.
[9] W. Qin,et al. MicroRNA‐155 is a novel suppressor of ovarian cancer‐initiating cells that targets CLDN1 , 2013, FEBS letters.
[10] Z. Zhan,et al. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma , 2013, Journal of Cardiothoracic Surgery.
[11] C. Chai,et al. The expression and significance of WWOX and β‐catenin in hepatocellular carcinoma , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[12] P. Dhawan,et al. Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner. , 2012, Carcinogenesis.
[13] M. Washington,et al. Caudal Homeobox Protein Cdx-2 Cooperates with Wnt Pathway to Regulate Claudin-1 Expression in Colon Cancer Cells , 2012, PloS one.
[14] K. Shirouzu,et al. Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer. , 2012, Anticancer research.
[15] Mingyao Liu,et al. Claudin 1 Mediates TNFα-Induced Gene Expression and Cell Migration in Human Lung Carcinoma Cells , 2012, PloS one.
[16] C. Du,et al. Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: A comparative analysis of three subgroups , 2012, Journal of surgical oncology.
[17] X. Chen,et al. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. , 2011, Gastroenterology.
[18] U. Cobanoglu,et al. Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas. , 2011, Pathology, research and practice.
[19] L. Montaño,et al. Claudin-6, 7, or 9 Overexpression in the Human Gastric Adenocarcinoma Cell Line AGS Increases Its Invasiveness, Migration, and Proliferation Rate , 2011, Cancer investigation.
[20] E. Leygue,et al. Claudin 1 in Breast Tumorigenesis: Revelation of a Possible Novel “Claudin High” Subset of Breast Cancers , 2010, Journal of biomedicine & biotechnology.
[21] X Chen,et al. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability , 2010, Oncogene.
[22] G. Yoon,et al. Claudin-1 Acts through c-Abl-Protein Kinase Cδ (PKCδ) Signaling and Has a Causal Role in the Acquisition of Invasive Capacity in Human Liver Cells* , 2009, The Journal of Biological Chemistry.
[23] Hyun Cheol Chung,et al. Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer , 2009, PLoS genetics.
[24] W. Hohenberger,et al. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front. , 2009, Experimental and molecular pathology.
[25] L. Murphy,et al. Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype , 2009, Virchows Archiv.
[26] Sung-Liang Yu,et al. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. , 2009, American journal of respiratory and critical care medicine.
[27] S. Zhang,et al. Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion. , 2008, World journal of gastroenterology.
[28] R. Mrsny,et al. A key claudin extracellular loop domain is critical for epithelial barrier integrity. , 2008, The American journal of pathology.
[29] J. Moldvay,et al. Distinct claudin expression profile in histologic subtypes of lung cancer. , 2007, Lung cancer.
[30] H. Kijima,et al. Decreased expression of claudin-1 correlates with recurrence status in breast cancer. , 2007, International journal of molecular medicine.
[31] Y. Matsuda,et al. Gastric and intestinal claudin expression at the invasive front of gastric carcinoma , 2007, Cancer science.
[32] M. Washington,et al. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. , 2007, Cancer research.
[33] S. Moss,et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. , 2005, Human pathology.
[34] M. Washington,et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. , 2005, The Journal of clinical investigation.
[35] N. Sawada,et al. Occludin expression decreases with the progression of human endometrial carcinoma. , 2004, Human pathology.
[36] S. Tsukita,et al. Claudin-based barrier in simple and stratified cellular sheets. , 2002, Current opinion in cell biology.
[37] J. Lee,et al. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. , 1995, Cancer research.
[38] M. Salto‐Tellez,et al. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. , 2010, Gastroenterology.
[39] I. Sporea,et al. Gastric cancer: correlation between clinicopathological factors and survival of patients (III). , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[40] I. Sporea,et al. Gastric cancer: correlation between clinicopathological factors and survival of patients. II. , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[41] Hermann Brenner,et al. Epidemiology of stomach cancer. , 2009, Methods in molecular biology.
[42] H. Helin,et al. Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype , 2005, Virchows Archiv.
[43] N. Niikawa,et al. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. , 2001, Oncology research.